SVRA Savara Inc Total Asset Value of Company
Savara Inc. (SVRA) enjoys an impeccable reputation among physicians and investors due to successful clinical trials of new drugs. This chart illustrates the current share price, reaching 177.96, which confirms the resilience of a business protected by patents in the rare lung pathology segment from pressure by industry behemoths. A steady inflow of funds enables the creation of exclusive therapeutic solutions for narrow niches where serious competitors are absent.
Analytical breakdowns and data insights for company Savara Corp (SVRA)
- market value and analyst target forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Savara Inc.|SVRA - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Savara Pharma|SVRA - Company Aggregate Debts|Debts to Book Capitalization Savara Pharma|SVRA - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Savara|Interim Coverage Ratio savarapharma.com
- net income and valuation multiples indicators:
Fundamental valuation:Savara Inc.
Total assets determine the aggregate volume of company resources, calculated reverse-engineered via return on assets (ROA) to identify hidden business degradation or growth. By analyzing asset trends through ROA, an investor can assess the scale of the capital base of Savara Inc. (SVRA), which is critical for the biopharmaceutical sector during the development of orphan lung disease therapies and expansion within the aPAP market.
Key competitors
argenx.com (ARGX) - Company Total Assets|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PGEN - Aggregate Company Assets|pharming.com (PHAR) - Cumulative Company Assets|Nektar Therapeutics Inc. (NKTR) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|Cumulative Company Assets ZBIO|Company Total Assets Immunome Bio|Aggregate Company Assets Gossamer Bio, Inc. (GOSS)|kalvista.com - Total Business Assets|Company Total Assets SEPN (Septerna)|Pieris Pharma (PVLA) - Company Assets|RIGL - Aggregate Company Assets|Company Total Asset Base AnaptysBio Inc. ANAB|ATXS: Company Total Assets|engene.com (ENGN) - Company Total Assets|Cumulative Company Assets RAPT|Aggregate Company Assets JBIO|Company Total Assets ACRS|Company Total Assets Kyverna Therapeutics, Inc (KYTX)|Aggregate Company Assets Tiziana Life Sciences TLSA|Aggregate Asset Value CABA|Ventyx Biosciences, Inc. - Company Total Assets|THTX - Company Total Assets|AVTX (Avalo Therapeutics Inc.) - Cumulative Company Assets|Eledon Pharmaceuticals, Inc - Aggregate Asset Value|AGEN (Agenus) - Company Total Assets|climbbio.com (CLYM) - Company Total Asset Base|Aggregate Company Assets Zura Bio (ZURA)|aTyr Pharma Inc - Total Business Assets|Company Total Assets ADAG (Adagene Inc.)|IMA - Cumulative Company Assets|STTK: Cumulative Company Assets|Company Total Asset Base Equillium, Inc. EQ|connectbiopharm.com (CNTB) - Aggregate Company Assets|IMUX - Company Total Asset Base|Cumulative Company Assets ATRA|Aggregate Company Assets IFRX|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|ACET (adicetbio.com) - Aggregate Asset Value|Company Total Assets CELU (Celularity)|Company Total Assets INmune Bio Inc INMB|BRNS - Aggregate Company Assets|Total Asset Value of Company KZR|SABS: Company Total Assets|akaritx.com - Aggregate Asset Value|ENLV (Enlivex Therapeutics Ltd) - Company Total Assets|Company Total Assets Q32 Bio Corp|Aggregate Company Assets GeoVax Labs Inc (GOVX)|EDSA (Edesa Biotech Corp) - Aggregate Asset Value|Aggregate Company Assets iBio, Inc. IBIO|CARM - Cumulative Company Assets|XTL Biopharmaceuticals Ltd. - Company Total Assets|BOLT - Company Total Assets|HCWB (hcwbiologics.com) - Cumulative Company Assets|Aptevo Therapeutics Inc. - Aggregate Asset Value|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Aditxt Corp (ADTX) - Company Total Asset Base|Aggregate Company Assets GRI Bio (GRI)|Cumulative Company Assets XORTX Therapeutics Inc XRTX|Aggregate Company Assets ReShape Lifesciences HIND|REVB - Cumulative Company Assets|INDP: Cumulative Company Assets|SCNI - Company Total Assets|calcimedica.com (CALI) - Aggregate Company Assets|Total Business Assets AFMD|ALLK (Allakos Inc) - Company Total Assets|Company Assets HOOKIPA HOOK|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|Company Total Asset Base iteostherapeutics.com|Company Total Assets OCEA (Ocean Biomedical)|Company Total Assets TC BioPharm (Holdings) Plc TCBP|THRD: Cumulative Company Assets